• Please log in or register to access this feature.

Perspective

You have full text access to this OnlineOpen article

Gene therapy enters the pharma market: The short story of a long journey

  1. Hildegard Büning†,*

Article first published online: 3 JAN 2013

DOI: 10.1002/emmm.201202291

Issue

EMBO Molecular Medicine

EMBO Molecular Medicine

Volume 5, Issue 1, pages 1–3, January 2013

Additional Information

How to Cite

Büning, H. (2013), Gene therapy enters the pharma market: The short story of a long journey. EMBO Mol Med, 5: 1–3. doi: 10.1002/emmm.201202291

Author Information

  1. Department I of Internal Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, CMMC Research Building, Cologne, Germany

  1. †

    Hildegard Büning, PhD, heads the Laboratory for AAV Vector Development, University of Cologne, and is the President of the German Society for Gene Therapy (DG-GT e.V., http://www.dg-gt.de).

*Tel: +49 221 478 89611; Fax: +49 221 478 97332

  1. †

    Hildegard Büning, PhD, heads the Laboratory for AAV Vector Development, University of Cologne, and is the President of the German Society for Gene Therapy (DG-GT e.V., http://www.dg-gt.de).

Publication History

  1. Issue published online: 3 JAN 2013
  2. Article first published online: 3 JAN 2013

Funded by

  • Funded Access

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (123K)

References

  • Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P et al (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270: 475- 480
  • Brunzell JD (1999) Familial lipoprotein lipase deficiency. In GeneReviews™ [Internet], Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) Seattle (WA): University of Washington
  • Buning H, Perabo L, Coutelle O, Quadt-Humme S, Hallek M (2008) Recent developments in adeno-associated virus vector technology. J Gene Med 10: 717- 733
    Direct Link:
  • Carpentier AC, Frisch F, Labbe SM, Gagnon R, de Wal J, Greentree S, Petry H, Twisk J, Brisson D, Gaudet D (2012) Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. J Clin Endocrinol Metab 97: 1635- 1644
  • Cavazzana-Calvo M, Fischer A, Hacein-Bey-Abina S, Aiuti A (2012) Gene therapy for primary immunodeficiencies: part 1. Curr Opin Immunol 24: 580- 584
  • Gaudet D, Methot J, Dery S, Brisson D, Essiembre C, Tremblay G, Tremblay K, de Wal J, Twisk J, van den Bulk N et al (2012a) Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther DOI: 10.1038/gt.2012.43
  • Gaudet D, Methot J, Kastelein J (2012b) Gene therapy for lipoprotein lipase deficiency. Curr Opin Lipidol 23: 310- 320
  • Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ (2011) Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124: 304- 313
  • Kay MA (2011) State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet 12: 316- 328
  • Mingozzi F, High KA (2011) Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12: 341- 355
  • Mingozzi F, Meulenberg JJ, Hui DJ, Basner-Tschakarjan E, Hasbrouck NC, Edmonson SA, Hutnick NA, Betts MR, Kastelein JJ, Stroes ES et al (2009) AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells. Blood 114: 2077- 2086
  • Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C, et al (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365: 2357- 2365
  • Stroes ES, Nierman MC, Meulenberg JJ, Franssen R, Twisk J, Henny CP, Maas MM, Zwinderman AH, Ross C, Aronica E et al (2008) Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol 28: 2303- 2304
  • Watts G (2012) Gene therapy to be authorised for first time in EU. Br Med J 345: e5009
View Full Article (HTML) Get PDF (123K)